Ganciclovir Gel (Zirgan)
An antiviral ophthalmic gel used to treat herpes simplex epithelial keratitis. Dosed less frequently than trifluridine and generally better tolerated.
Drug Class: Antiviral
Ganciclovir 0.15% ophthalmic gel (brand name Zirgan) is a topical antiviral used to treat epithelial herpes simplex virus (HSV) keratitis - the dendritic and geographic ulcers that develop during active herpes infection of the cornea. It is one of two main agents used for this purpose; the other is trifluridine. Ganciclovir gel is preferred at many practices because of more convenient dosing and better corneal tolerance.
Key Takeaways
- Used for active epithelial HSV keratitis - dendritic and geographic ulcers
- Dosed five times daily during active infection - significantly less demanding than trifluridine's nine doses per day
- Most cases resolve in 7-10 days with adherent treatment
- Better tolerated than trifluridine - less corneal toxicity and stinging
- Not effective alone for stromal HSV, uveitis, or retinitis - those forms require oral antiviral therapy and other measures
How It Works
Ganciclovir is a guanosine analog. It is selectively monophosphorylated by viral thymidine kinase in HSV-infected cells; host cellular kinases then add the second and third phosphates. The active triphosphate is incorporated into viral DNA and terminates replication. The gel formulation provides extended contact with the corneal surface, which permits a less frequent dosing schedule than the older trifluridine 1% solution.
Common Uses
- Epithelial HSV keratitis - dendritic and geographic ulcers; the primary indication
- Recurrent episodes - used during each acute attack
- Approved for adults and children ≥2 years
Not Indicated For
- Stromal keratitis - typically treated with oral acyclovir family agents and carefully managed topical steroids
- HSV uveitis or retinitis - systemic treatment is required
- Long-term prophylaxis - oral valacyclovir or acyclovir is the standard for ongoing recurrence prevention
How to Use
- Active infection dosing: One drop in the affected eye 5 times daily (approximately every 3 hours while awake) until the corneal ulcer heals - typically 7-10 days
- Maintenance after reepithelialization: 3 times daily for 7 days after healing
- Storage: Store at room temperature (15-25°C / 59-77°F); do not freeze
- Multiple drops: Wait at least 5 minutes between different eye drops
- Contact lenses: Do not wear during treatment
What to Expect
- Pain and photophobia improve within 2-4 days
- The dendritic ulcer fades over 5-10 days
- Reepithelialization in 7-10 days for most patients
- Less stinging on instillation than trifluridine
- Less corneal toxicity over the course of treatment
Side Effects
Local
- Mild blurred vision transiently after instillation (the gel temporarily clouds the tear film)
- Conjunctival hyperemia
- Mild eye irritation - typically less than trifluridine
- Punctate corneal staining - uncommon
- Allergic blepharoconjunctivitis - uncommon
Systemic
- Negligible - minimal systemic absorption from topical gel
Ganciclovir Gel vs. Trifluridine
| Feature | Ganciclovir gel | Trifluridine |
|---|---|---|
| Concentration | 0.15% gel | 1% solution |
| Dosing during active infection | 5× daily | 9× daily |
| Dosing after reepithelialization | 3× daily for 7 days | 5× daily for 7 days |
| Tolerance | Better | More stinging and toxicity |
| Mechanism | Guanosine analog (requires viral TK) | Thymidine analog (TK-independent) |
| Resistance | Susceptible to TK-deficient HSV | Effective against TK-deficient HSV |
| Available since | 2009 (US) | 1980 |
| Cost | Brand more expensive | Generic available, but U.S. supply and price can vary |
For many patients, ganciclovir gel is preferred because of more convenient dosing and less corneal toxicity. Trifluridine retains activity against thymidine-kinase-deficient HSV, which is uncommon in immunocompetent patients but more frequent in immunocompromised hosts.
Adjunctive Therapy
Mechanical Debridement
For dendritic ulcers, gentle debridement of loose epithelium with a sterile cotton swab is sometimes performed in addition to antiviral therapy.
Oral Antivirals
Valacyclovir, acyclovir, or famciclovir are added for stromal disease, recurrent disease, or as prophylaxis. The HEDS trials established the value of oral antivirals in many forms of HSV eye disease.
Topical Steroids
- Avoided in active epithelial disease
- Used carefully in stromal keratitis under supervision, often combined with oral antiviral coverage
Frequently Asked Questions
Why do many clinicians prefer ganciclovir gel over trifluridine?
Two reasons: dosing is far more convenient (5 times daily vs 9), and corneal tolerance is better. The trade-off is that ganciclovir is susceptible to thymidine-kinase-deficient HSV strains, while trifluridine is effective against them. In typical first episodes of HSV keratitis, ganciclovir gel is commonly preferred where available and tolerated.
Is the gel as effective as the trifluridine drops?
Head-to-head studies have shown ganciclovir gel is comparable in efficacy to trifluridine for typical epithelial HSV keratitis, with similar resolution rates and times to healing.
Why does my vision blur after putting in the gel?
The gel temporarily forms a film over the cornea that smooths out and clears within minutes to half an hour. This brief blurring is expected and is not a side effect to worry about. Many patients dose the gel before periods of less critical visual demand.
Can I wear contact lenses during treatment?
No. Active herpes keratitis is a contraindication to contact lens wear. Resume contact lens use only after full healing and clearance from your doctor.
What happens if my ulcer does not heal in 10 days?
The doctor will reassess. Sometimes the agent is switched (often to trifluridine), sometimes oral antivirals are added, sometimes the diagnosis is reconsidered. Persistent dendritic ulcers may indicate resistance, atypical HSV, or another diagnosis.
Is this the same as systemic ganciclovir for cytomegalovirus?
Same active molecule, different application. IV ganciclovir or oral valganciclovir (the prodrug converted to ganciclovir in the body) is used systemically for cytomegalovirus disease in immunocompromised patients. Ganciclovir gel is a topical formulation used only for ocular HSV at much lower total exposure.
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Follow your doctor's instructions regarding this medication.
Sources:
- DailyMed. ZIRGAN (ganciclovir ophthalmic gel) prescribing information.
- Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015;(1):CD002898.
